Position in GSK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$6,750,018
+$62,370 QoQ
Shares Held
128,768
+6.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#133
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gilman Hill Asset Management, LLC holds $40,633,070 across 8 Drug Manufacturers - General names. GSK ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
231,255 | $13,324,913 | |
| 2 | PFE |
Pfizer Inc
|
428,237 | $10,311,946 | |
| 3 | GSK |
GSK plc
This page
|
128,768 | $6,750,018 | |
| 4 | ABBV |
AbbVie Inc.
|
13,594 | $3,420,794 | |
| 5 | JNJ |
Johnson & Johnson
|
12,793 | $3,249,038 | |
| 6 | LLY |
ELI LILLY & Co
|
1,606 | $1,926,284 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,457 | $1,343,724 | |
| 8 | AMGN |
Amgen Inc
|
846 | $306,353 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,750,018 | 128,768 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $6,687,648 | 121,175 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $6,220,625 | 126,848 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $5,321,973 | 123,308 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $4,564,800 | 118,875 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,706,415 | 69,861 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,173,340 | 64,262 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,756,211 | 67,422 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $2,366,094 | 61,457 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,462,967 | 57,452 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,023,290 | 54,595 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,189,862 | 60,410 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,203,941 | 61,839 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,983,727 | 55,754 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,821,763 | 51,843 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,631,864 | 55,449 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $3,025,696 | 70,869 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,983,477 | 69,832 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $2,761,029 | 63,834 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,428,618 | 64,804 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $2,340,163 | 59,919 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $2,096,049 | 59,879 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,038,701 | 56,484 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,290,149 | 34,947 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,434,124 | 35,847 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,355,576 | 36,477 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||